Longevity Articles

Are We Slowing Aging—or Just Moving Its Markers?

Are We Slowing Aging—or Just Moving Its Markers?

Key takeaways

  • Yale researchers analyzed 51 human clinical studies using more than 110 DNA methylation biomarkers, including 16 major epigenetic clocks.

  • Diet combined with exercise and certain prescription medications were associated with favorable changes in aging markers.

  • The over-the-counter supplements examined generally showed little measurable effect.

  • Lowering an aging-clock score does not establish longer life, better function, or lasting health benefits.

Biological-age tests promise a glimpse beyond birthdays. But whether their readings respond meaningfully to an intervention is a separate question.

Researchers led by Raghav Sehgal and Albert Higgins-Chen at Yale examined how DNA-based aging markers changed across studies of medications, lifestyle interventions, supplements, and medical procedures.

These epigenetic clocks analyze chemical tags on DNA to estimate aspects of biological aging. They measure patterns associated with aging—not aging itself in its entirety.

Lifestyle changes and medications showed signals

Combining physical activity with dietary changes consistently produced favorable shifts in epigenetic age. The eating patterns studied included Mediterranean, low-fat, and low-carbohydrate diets.

Certain prescription treatments—including metformin, semaglutide, and medications targeting TNF, an immune-signaling protein—were associated with some of the strongest reductions in aging markers.

By contrast, the supplements and some medical procedures examined showed little measurable benefit on these tests. That finding applies to the interventions and measurements included, not every supplement or possible health outcome.

A younger score is not proof of rejuvenation

Newer clocks were more responsive than older versions, underscoring that the result depends partly on the measurement tool.

The researchers also emphasized unresolved questions: Do changes persist? Which biological processes drive them? And do they translate into better long-term health or function?

The analysis does not establish that healthy people should take prescription medication to lower a biological-age score.

The takeaway

Some interventions can move aging biomarkers. The harder—and more important—task is establishing whether those changes represent benefits people can actually experience.

References:

  1. Raghav Sehgal, Daniel Borrus, Jenel F. Armstrong, John Gonzalez, Jessica Kasamoto, Yaroslav Markov, Ahana Priyanka, Ryan Smith, Natàlia Carreras-Gallo, Jessica Lasky-Su, Varun B. Dwaraka, Michael J. Corley, Albert Higgins-Chen. Responsiveness of epigenetic aging biomarkers to longevity interventions in humans. Nature Medicine, 2026; 32 (9): 3477 DOI: 10.1038/s41591-026-04562-9


← Older post Newer post →